10 students will travel to Japan as part of the Sakura Science Plan 2020


On January 12, a delegation of 10 students from the Universidad Peruana Cayetano Heredia (UPCH) will travel to the city of Miyazaki, Japan for a 10-day internship.

This internship was coordinated by the Miyazaki University and the Instituto de Medicina Tropical “Alexander von Humboldt”, funded by the Japan Science and Technology Agency (JST) as part of the Sakura Science Plan 2020, which seeks to strengthen the good relationship between Japan and other countries and regions, promote globalization of Japan’s education and research institutes, and support the development of talented people overseas, who have the potential to contribute to innovation in science and technology.

The delegation will participate in the Course C of the Sakura Science Plan 2020, which is focused in training so that participants can acquire specific techniques and skills related to science and technology that host institutions perform.

The student delegation is conformed by the medicine students Catalina Aron Said (3rd year), Rodrigo Calmet (4th year), Belén Gambirazio Alvarado (4th year), Jhon Bocanegra Becerra (5th year), Ronald Cadillo Hernández (5th year), Martha Guevera (6th year), Jorge Nakazaki Aza (7th year), and Master candidates Daniel Enríquez Vera (Medical Oncologist, Master program in Medicine with mention in Oncology), Jessica Cuenca Iglesias (Master program in Biochemistry and Molecular Biology) and Jen Campos Tineo (Master program in Biochemistry and Molecular Biology).

Special thanks to the University of Miyazaki and to Dr. Martín Montes, Head of the Immunology Lab of the IMT AvH (InmunoLab), who was in charge of the coordination of this internship, and will also accompany the delegation.

The collaboration between the University of Miyazaki and the IMT AvH began in 2016, with whom we have been working in different research areas such as immunology of HTLV-1 and co-infections (strongyloidiasis, fungal infections), human strongyloidiasis and adult T-cell leukemia/lymphoma (ATL).